Wednesday, July 16, 2025 7/16/2025

CUSTOMIZED NANOFILTRATION MEMBRANES FOR ENHANCING PHARMACEUTICAL MANUFACTURING

Award Number: R43GM093710
ORGANIZATION: NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 09/01/2011
PERIOD OF PERFORMANCE END DATE: 08/31/2014

Group Awards By:

View Award Description

CUSTOMIZED NANOFILTRATION MEMBRANES FOR ENHANCING PHARMACEUTICAL MANUFACTURING - DESCRIPTION (provided by applicant): The overall focus of this application is to develop nanofiltration membranes to recover the spent solvents generated from drug manufacturing processes allowing the solvents to be reused resulting in elimination of waste. This is also responsive to NIH RFP PA-09-100 entitled "Energy Efficiency and Renewable Energy System Technology Research & Development". By using a pressure-driven nanofiltration versus a thermal-driven separation such as distillation for recovery of pharmaceutical spent solvents, we also are directly responsive to this NIH's RFP for energy efficient processes. Chemical syntheses in the pharmaceutical industry are often carried out in solvents and generate large amount of spent solvents. Extraction and purification of pharmaceutical ingredients and cleaning of the drug manufacturing equipment such as reactors also generate solvent effluents. There are numerous needs in the pharmaceutical industry that involve the treatment of these organic solvents. They include: i) production of high purity solvents for organic synthesis ii) recovery of spent organic solvents to reduce the amount of toxic waste produced. The current application is addressed to remove contaminants from spent organic solvents generated from the production of bulk pharmaceutical substances. Nanofiltration separation, driven by the applied pressure gradient, allows solvents to permeate selectively through the membrane retaining the solutes and non-selective solvents. Most of the waste solvents produced in the drug manufacturing processes contain low molecular compounds or solutes such as spent catalysts and by-products with molecular weight less than 1000 g/mol. The spent solvents often contain azeotropic solvent mixtures that can not be separated easily. PUBLIC HEALTH RELEVANCE: This project will develop a membrane product and process to remove dissolved oxygen and water from reaction solvents and reactants as well as unreacted chemicals, spent catalysts and byproducts from spent organic solvents. This development has considerable significance to reduce production costs related to pharmaceutical manufacturing.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2013 ( Subtotal = $0 )
2013	2011	COMPACT MEMBRANE SYSTEMS, INC	325 HAMPTON ROAD	WILMINGTON	DE	19803	NEW CASTLE	USA	Biomedical Research and Research Training	000	1	7/25/2013	NEW	$0
														Subtotal = $0

Issue Date FY: 2011 ( Subtotal = $161,657 )
2011	2011	COMPACT MEMBRANE SYSTEMS, INC	335 Water St	Wilmington	DE	19804	NEW CASTLE	USA	Biomedical Research and Research Training	000	1	8/22/2011	NEW	$161,657
														Subtotal = $161,657

Grand Total All Awards = $161,657

Top

All Categories

About

Search

Reports

Data Submission

Award Information

CUSTOMIZED NANOFILTRATION MEMBRANES FOR ENHANCING PHARMACEUTICAL MANUFACTURING

Award Number: R43GM093710

ORGANIZATION: NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 09/01/2011

PERIOD OF PERFORMANCE END DATE: 08/31/2014

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer